BioNote Inc.
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-… Read more
Market Cap & Net Worth: BioNote Inc. (377740)
BioNote Inc. (KO:377740) has a market capitalization of $370.12 Million (₩541.93 Billion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #21045 globally and #962 in its home market, demonstrating a 0.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioNote Inc.'s stock price ₩5370.00 by its total outstanding shares 100917479 (100.92 Million).
BioNote Inc. Market Cap History: 2022 to 2026
BioNote Inc.'s market capitalization history from 2022 to 2026. Data shows change from $565.11 Million to $370.12 Million (-16.55% CAGR).
BioNote Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioNote Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
BioNote Inc.'s market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
BioNote Inc.'s market cap is 0.00 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $565.11 Million | $479.66 Billion | $307.80 Billion | 0.00x | 0.00x |
Competitor Companies of 377740 by Market Capitalization
Companies near BioNote Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to BioNote Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
BioNote Inc. Historical Marketcap From 2022 to 2026
Between 2022 and today, BioNote Inc.'s market cap moved from $565.11 Million to $ 370.12 Million, with a yearly change of -16.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩370.12 Million | -1.83% |
| 2025 | ₩377.01 Million | +16.14% |
| 2024 | ₩324.63 Million | +16.11% |
| 2023 | ₩279.59 Million | -50.52% |
| 2022 | ₩565.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioNote Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $370.12 Million USD |
| MoneyControl | $370.12 Million USD |
| MarketWatch | $370.12 Million USD |
| marketcap.company | $370.12 Million USD |
| Reuters | $370.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.